Cargando…
Preclinical and Clinical Evidence of Therapeutic Agents for Paclitaxel-Induced Peripheral Neuropathy
Paclitaxel is an essential drug in the chemotherapy of ovarian, non-small cell lung, breast, gastric, endometrial, and pancreatic cancers. However, it frequently causes peripheral neuropathy as a dose-limiting factor. Animal models of paclitaxel-induced peripheral neuropathy (PIPN) have been establi...
Autores principales: | Kawashiri, Takehiro, Inoue, Mizuki, Mori, Kohei, Kobayashi, Daisuke, Mine, Keisuke, Ushio, Soichiro, Kudamatsu, Hibiki, Uchida, Mayako, Egashira, Nobuaki, Shimazoe, Takao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8396047/ https://www.ncbi.nlm.nih.gov/pubmed/34445439 http://dx.doi.org/10.3390/ijms22168733 |
Ejemplares similares
-
Inhibitory Effect of α1 Receptor Antagonists on Paclitaxel-Induced Peripheral Neuropathy in a Rodent Model and Clinical Database
por: Mori, Kohei, et al.
Publicado: (2022) -
Therapeutic Agents for Oxaliplatin-Induced Peripheral Neuropathy; Experimental and Clinical Evidence
por: Kawashiri, Takehiro, et al.
Publicado: (2021) -
Omeprazole Suppresses Oxaliplatin-Induced Peripheral Neuropathy in a Rodent Model and Clinical Database
por: Mine, Keisuke, et al.
Publicado: (2022) -
Neuroprotective effect of alogliptin on oxaliplatin-induced peripheral neuropathy in vivo and in vitro
por: Shigematsu, Nao, et al.
Publicado: (2020) -
Use of omeprazole, the proton pump inhibitor, as a potential therapy for the capecitabine-induced hand-foot syndrome
por: Hiromoto, Shiori, et al.
Publicado: (2021)